Importantly, correction of insulin resistance, along with other related mechanisms, through the use of add-on insulin sensitizer therapy, has been demonstrated in clinical trials to improve antidepressant treatment response in patients with treatment-resistant depression [18, 19]. Here, INS is linked to depressive disorder.